JP4262776B2 - 均一薬物投与療法 - Google Patents

均一薬物投与療法 Download PDF

Info

Publication number
JP4262776B2
JP4262776B2 JP53622297A JP53622297A JP4262776B2 JP 4262776 B2 JP4262776 B2 JP 4262776B2 JP 53622297 A JP53622297 A JP 53622297A JP 53622297 A JP53622297 A JP 53622297A JP 4262776 B2 JP4262776 B2 JP 4262776B2
Authority
JP
Japan
Prior art keywords
drug
composition
microns
dosage form
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP53622297A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000508313A (ja
JP2000508313A5 (es
Inventor
エア,アトゥル・デブダット
ラム,アンドリュー
マグルーダー,ジュディー・エイ
ハメル,ローレンス・ジー
ウォン,パトリック・エス・エル
Original Assignee
アルザ・コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アルザ・コーポレーション filed Critical アルザ・コーポレーション
Publication of JP2000508313A publication Critical patent/JP2000508313A/ja
Publication of JP2000508313A5 publication Critical patent/JP2000508313A5/ja
Application granted granted Critical
Publication of JP4262776B2 publication Critical patent/JP4262776B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP53622297A 1996-04-05 1997-03-20 均一薬物投与療法 Expired - Lifetime JP4262776B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1488996P 1996-04-05 1996-04-05
US60/014,889 1996-04-05
PCT/US1997/004495 WO1997037640A2 (en) 1996-04-05 1997-03-20 Uniform drug delivery therapy

Publications (3)

Publication Number Publication Date
JP2000508313A JP2000508313A (ja) 2000-07-04
JP2000508313A5 JP2000508313A5 (es) 2005-02-10
JP4262776B2 true JP4262776B2 (ja) 2009-05-13

Family

ID=21768382

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53622297A Expired - Lifetime JP4262776B2 (ja) 1996-04-05 1997-03-20 均一薬物投与療法

Country Status (14)

Country Link
EP (1) EP0907358B1 (es)
JP (1) JP4262776B2 (es)
AR (1) AR006087A1 (es)
AT (1) ATE210429T1 (es)
AU (1) AU710389B2 (es)
BR (1) BR9708528A (es)
DE (1) DE69709101T2 (es)
DK (1) DK0907358T3 (es)
ES (1) ES2166988T3 (es)
HK (1) HK1020523A1 (es)
NZ (1) NZ332014A (es)
PT (1) PT907358E (es)
WO (1) WO1997037640A2 (es)
ZA (1) ZA97976B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
WO1999001121A1 (en) 1997-07-01 1999-01-14 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
EA002481B1 (ru) * 1997-07-01 2002-06-27 Пфайзер Продактс Инк. Композиция на основе солюбилизированного сертралина
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
JP2002528486A (ja) * 1998-11-02 2002-09-03 アルザ・コーポレーション 有効物質の送達制御
AU1789301A (en) * 1999-11-22 2001-06-04 Alza Corporation Osmotic dosage form comprising first and second
CA2395231C (en) * 1999-12-23 2006-08-15 Pfizer Products Inc. Hydrogel-driven layered drug dosage form
CA2420038C (en) 2000-08-30 2010-11-09 John Hopkins University Devices for intraocular drug delivery
WO2003000177A2 (en) * 2001-06-21 2003-01-03 Andrx Pharmaceuticals, Inc. Stable controlled release pharmaceutical compositions containing pravastatin
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
KR100795419B1 (ko) * 2006-01-03 2008-01-17 (주)네오메딕스 암로디핀 및 아스피린을 함유하는 약학 제제
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
MX351261B (es) 2012-06-01 2017-10-06 Surmodics Inc Aparato y método para recubrir catéteres con globo.
JP2016520653A (ja) 2013-06-05 2016-07-14 シンクロニューロン インコーポレイテッド アカンプロサート製剤、それを用いる方法、およびそれを含む合剤
US11628466B2 (en) 2018-11-29 2023-04-18 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
CN118742293A (zh) * 2022-01-31 2024-10-01 住友精化株式会社 药物控释制剂用组合物和药物控释制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1503116A (en) * 1975-07-28 1978-03-08 Alza Corp Sustained release drug delivery devices
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs

Also Published As

Publication number Publication date
DE69709101T2 (de) 2002-04-25
JP2000508313A (ja) 2000-07-04
DE69709101D1 (de) 2002-01-24
EP0907358B1 (en) 2001-12-12
AR006087A1 (es) 1999-08-11
NZ332014A (en) 1999-04-29
EP0907358A2 (en) 1999-04-14
HK1020523A1 (en) 2000-05-12
BR9708528A (pt) 1999-08-03
DK0907358T3 (da) 2002-03-25
ZA97976B (en) 1997-08-18
WO1997037640A2 (en) 1997-10-16
ES2166988T3 (es) 2002-05-01
ATE210429T1 (de) 2001-12-15
WO1997037640A3 (en) 1997-11-13
AU710389B2 (en) 1999-09-16
AU2337897A (en) 1997-10-29
PT907358E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
US6534089B1 (en) Uniform drug delivery therapy
JP4262776B2 (ja) 均一薬物投与療法
US20020114838A1 (en) Uniform drug delivery therapy
KR100618234B1 (ko) 다공성 입자를 포함하는 제형
JP4500679B2 (ja) パリペリドンを制御送達する方法および投薬形態物
US6342249B1 (en) Controlled release liquid active agent formulation dosage forms
JP2796433B2 (ja) 時間変動パターンでの薬物送達のための剤形
CA2395231C (en) Hydrogel-driven layered drug dosage form
JP2008510000A (ja) 制御放出性ナノ粒子有効薬剤配合物投与剤型品および方法
KR20010075676A (ko) 활성 제제의 제어 수송
JP2003509354A (ja) 1日1回投与で有効なレボキセチン治療を与える製剤及び方法
CZ189597A3 (cs) Dávkovací prostředek pro řízené uvolňování suspenze léčiva
JPH02229110A (ja) ヒドロゲルを用いた徐放製剤
CN1988884B (zh) 控制释放基质的药物剂型组成
MXPA06002067A (es) Suministro gradual de topiramato durante periodo prolongado.
JP2006517593A (ja) 投薬形態物の層形状修飾方法およびそのような修飾を受けさせた投薬形態物
JP2002514592A (ja) 抗うつ剤療法
JPH0784385B2 (ja) 有用な薬剤クロルフエニラミン供給用剤形
KR100734193B1 (ko) 항우울제의 제어된 전달
KR100468334B1 (ko) 균일한약제전달치료
CA2586473C (en) Uniform drug delivery therapy
CA2249637C (en) Uniform drug delivery therapy
JP2948906B2 (ja) 薬剤を投与して概日治療を行うための剤形
US20030203029A1 (en) Controlled release liquid active agent formulation dosage forms
JP2006522016A (ja) 改変された粘度の層を用いる方法および投薬形態物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20040322

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040427

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070925

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20071221

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081031

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20090113

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20090210

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120220

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120220

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130220

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130220

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140220

Year of fee payment: 5

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term